{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:47:56Z","timestamp":1790689676356,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422174053"],"award-info":[{"award-number":["422174053"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejphar.2022.174935","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:43:25Z","timestamp":1648845805000},"page":"174935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration"],"prefix":"10.1016","volume":"923","author":[{"given":"Petra","family":"Bloms-Funke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Liere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Nothdurfter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Bahrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Christoph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0685-1810","authenticated-orcid":false,"given":"Christa","family":"Kneip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Tzschentke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.174935_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/j.1532-2149.2013.00367.x","article-title":"Etifoxine stimulates allopregnanolone synthesis in the spinal cord to produce analgesia in experimental mononeuropathy","volume":"18","author":"Aouad","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2022.174935_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.psyneuen.2019.03.029","article-title":"Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells","volume":"106","author":"Bader","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.ejphar.2022.174935_bib3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/jcbfm.2015.83","article-title":"Protective role of Kv7 channels in oxygen and glucose deprivation-induced damage in rat caudate brain slices","volume":"35","author":"Barrese","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174935_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/j.pain.0000000000000350","article-title":"Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine","volume":"157","author":"Bellows","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2022.174935_bib5","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.ejphar.2022.174935_bib6","doi-asserted-by":"crossref","first-page":"108884","DOI":"10.1016\/j.neuropharm.2021.108884","article-title":"The novel dual mechanism Kv7 potassium channel\/TSPO receptor agonist GRT-X is more effective than the Kv7 channel opener retigabine to block difficult-to-treat epileptic seizures in rodent models","volume":"203","author":"Bloms-Funke","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2022.174935_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/jpet.108.139410","article-title":"Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy","volume":"326","author":"Bordet","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.174935_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"21","key":"10.1016\/j.ejphar.2022.174935_bib9","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1523\/JNEUROSCI.18-21-08674.1998","article-title":"Contributions of pathway and neuron to preferential motor reinnervation","volume":"18","author":"Brushart","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.174935_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.neuro.30.051606.094337","article-title":"Peripheral regeneration","volume":"30","author":"Chen","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2022.174935_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.174935_bib12","doi-asserted-by":"crossref","first-page":"18164","DOI":"10.1038\/srep18164","article-title":"TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy","volume":"6","author":"Costa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2022.174935_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3959(93)90059-X","article-title":"Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain","volume":"53","author":"Courtiex","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2022.174935_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.pbb.2007.01.013","article-title":"Morphine-induced place conditioning in Fischer and Lewis rats: acquisition and dose-response in a fully biased procedure","volume":"86","author":"Davis","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2022.174935_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2165\/11536230-000000000-00000","article-title":"Flupirtine in pain management: pharmacological properties and clinical use","volume":"24","author":"Devulder","year":"2010","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.ejphar.2022.174935_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-0270(99)00174-0","article-title":"Methods to evaluate functional nerve recovery in adult rats: walking track analysis, video analysis and the withdrawal reflex","volume":"96","author":"Dijkstra","year":"2000","journal-title":"J. Neurosci. Methods"},{"issue":"3","key":"10.1016\/j.ejphar.2022.174935_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ejphar.2022.174935_bib18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/jpet.301.3.1067","article-title":"SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1 -acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair","volume":"301","author":"Ferzaz","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.174935_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2022.174935_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1479-5876-11-34","article-title":"Activation of axonal Kv channels in human peripheral nerve by flupirtine but placebo \u2013 therapeutic potential for peripheral neuropathies: results of a randomised controlled trial","volume":"11","author":"Fleckenstein","year":"2013","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174935_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.neuroscience.2009.08.005","article-title":"Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy","volume":"164","author":"Giatti","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2022.174935_bib22","doi-asserted-by":"crossref","first-page":"20505","DOI":"10.1073\/pnas.0811201106","article-title":"Etifoxine improves peripheral nerve regeneration and functional recovery","volume":"105","author":"Girard","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.ejphar.2022.174935_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajog.2010.06.011","article-title":"Steroid profiling in preeclamptic women: evidence for aromatase deficiency","volume":"203","author":"Hertig","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"135","key":"10.1016\/j.ejphar.2022.174935_bib24","first-page":"36791","article-title":"Safety pharmacology studies for human pharmaceuticals","volume":"66","year":"2001","journal-title":"Fed. Regist."},{"key":"10.1016\/j.ejphar.2022.174935_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.expneurol.2015.02.033","article-title":"Mirror-image pain after nerve reconstruction in rats is related to enhanced density of epidermal peptidergic nerve fibers","volume":"267","author":"Kambiz","year":"2015","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.174935_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0166-2236(98)01302-2","article-title":"Does the right side know what the left is doing?","volume":"22","author":"Koltzenburg","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2022.174935_bib27","unstructured":"K\u00fchnert S, Bahrenberg G, Kless A, Schr\u00f6der W, inventors; Gr\u00fcnenthal GmbH, assignee. Substituted 2-oxo-and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2\/3 modulators. Patent family based on WO 2012\/025239. Publication date 1 Mar 2012. International Application No. PCT\/EP2011\/004280. International Filing Date 26 Aug 2011."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174935_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(98)01105-6","article-title":"Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis","volume":"815","author":"Lacor","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2022.174935_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0024-3205(83)90794-4","article-title":"Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]Ro5-4864 and [3H]PK 11195, by thermodynamic studies","volume":"33","author":"Le Fur","year":"1983","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2022.174935_bib30","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1194\/jlr.M400244-JLR200","article-title":"Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain","volume":"45","author":"Liere","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2022.174935_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.psyneuen.2017.05.022","article-title":"Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: pharmacodynamic studies","volume":"83","author":"Liere","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.ejphar.2022.174935_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.114.213694","article-title":"Cebranopadol: a novel potent analgesic nociceptin\/OrphaninFQ peptide and opioid receptor agonists","volume":"349","author":"Linz","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.174935_bib33","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/mus.880141113","article-title":"Changes in nerve fibre numbers distal to nerve repair in the rat sciatic nerve model","volume":"14","author":"Mackinnon","year":"1991","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ejphar.2022.174935_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0304-3959(00)00332-8","article-title":"Patterns of spread in complex regional pain syndrome, type I (reflex sympathetic dystrophy)","volume":"88","author":"Maleki","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2022.174935_bib35","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1113\/jphysiol.2008.150656","article-title":"Nervous system Kv7 disorders: breakdown of a subthreshold brake","volume":"586","author":"Maljevic","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2022.174935_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0047-6374(00)00112-3","article-title":"Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease","volume":"116","author":"M\u00fcller","year":"2000","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ejphar.2022.174935_bib37","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2147\/NDT.S200568","article-title":"An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action","volume":"15","author":"Nuss","year":"2019","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174935_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12500","article-title":"Translocator protein (18 kDa): an update on its function in steroidogenesis","volume":"30","author":"Papadopoulos","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2022.174935_bib39","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.174935_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnmol.2012.00063","article-title":"Functional significance of M-type potassium channels in nociceptive cutaneous sensory endings","volume":"5","author":"Passmore","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2022.174935_bib41","first-page":"70","article-title":"Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain","volume":"113","author":"Patte-Mensah","year":"2014","journal-title":"Neurobiology"},{"key":"10.1016\/j.ejphar.2022.174935_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fncel.2014.00174","article-title":"Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone","volume":"8","author":"Poisbeau","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.ejphar.2022.174935_bib43","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2022.174935_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(97)01249-1","article-title":"The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells","volume":"336","author":"Rundfeldt","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"5939","key":"10.1016\/j.ejphar.2022.174935_bib45","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.1175055","article-title":"Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects","volume":"325","author":"Rupprecht","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2022.174935_bib46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd3295","article-title":"Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders","volume":"9","author":"Rupprecht","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2022.174935_bib47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1369-1600.2010.00235.x","article-title":"The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats","volume":"16","author":"Rutten","year":"2010","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2022.174935_bib48","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2353\/ajpath.2008.080491","article-title":"Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis","volume":"173","author":"S\u00e4ttler","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2022.174935_bib49","first-page":"387","article-title":"Is there any correlation between binding and functional effects at the Translocator Protein (TSPO, 18 kDa)?","volume":"12","author":"Scarf","year":"2012","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174935_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","article-title":"Classification committee of the neuropathic pain special interest group (NeuPSIG) the IASP classification of chronic pain for ICD-11: chronic neuropathic pain","volume":"160","author":"Scholz","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2022.174935_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnins.2012.00010","article-title":"Progesterone synthesis in the nervous system: implications for myelination and myelin repair","volume":"6","author":"Schumacher","year":"2012","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2022.174935_bib52","unstructured":"Str\u00fcnker T, Cavalar M, Bahrenberg G, inventors; Gr\u00fcnenthal GmbH, assignee. Method for identifying the agonistic or antagonistic activity of a target compound on a potassium channel. WO 2008\/110247. Publication date 18 Sep 2008. International Application No. PCT\/EP2008\/001161. International Filing Date 15 Feb 2008."},{"key":"10.1016\/j.ejphar.2022.174935_bib53","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(94)90130-9","article-title":"Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain","volume":"58","author":"Sulfka","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2022.174935_bib54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/brain\/74.4.491","article-title":"A classification of peripheral nerve injuries producing loss of function","volume":"74","author":"Sunderland","year":"1951","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ejphar.2022.174935_bib55","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.pbb.2005.11.013","article-title":"The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain","volume":"82","author":"Verleye","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2022.174935_bib56","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fphys.2020.00688","article-title":"Pharmacological manipulation of Kv 7 channels as a new Therapeutic tool for multiple brain disorders","volume":"11","author":"Vigil","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2022.174935_bib57","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3171\/2013.1.JNS121176","article-title":"Combination of hypoglossal-facial nerve surgical reconstruction and neurotrophin-3 gene therapy for facial palsy","volume":"119","author":"Wan","year":"2013","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174935_bib58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3171\/2013.9.JNS13664","article-title":"Hypoglossal-facial nerve \"side\"-to-side neurorrhaphy for persistent incomplete facial palsy","volume":"120","author":"Wan","year":"2014","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejphar.2022.174935_bib59","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1523\/JNEUROSCI.0324-12.2013","article-title":"The upregulation of translocator protein (18 kDa) promotes recovery from neuropathic pain in rats","volume":"33","author":"Wei","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.174935_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/13543776.14.4.457","article-title":"KCNQ potassium channels: drug targets for the treatment of epilepsy and pain","volume":"14","author":"Wickenden","year":"2004","journal-title":"Expert Opin. Ther. Pat."},{"issue":"3","key":"10.1016\/j.ejphar.2022.174935_bib61","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/mol.107.043216","article-title":"N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2\/Q3 potassium channel activator","volume":"73","author":"Wickenden","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174935_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0034-1398507","article-title":"Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines","volume":"48","author":"Wolf","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2022.174935_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:17:11Z","timestamp":1762143431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":63,"alternative-id":["S0014299922001960"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174935","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174935"}}